Treatment for hepatitis C virus with pegylated interferon-α plus ribavirin induces anti-atherogenic effects on cardiovascular risk biomarkers in HIV-infected and -uninfected patients

Bibliographic Details
Title: Treatment for hepatitis C virus with pegylated interferon-α plus ribavirin induces anti-atherogenic effects on cardiovascular risk biomarkers in HIV-infected and -uninfected patients
Authors: Masiá, M., Robledano, C., López, N., Escolano, C., Gutiérrez, F. x.
Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 66(8):1861-1868
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN300129054&indx=1&recIds=ETOCRN300129054
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:03057453
Published in:JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Language:English